{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:49:38Z","timestamp":1782107378586,"version":"3.54.5"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Febrile neutropenia causes substantial morbidity in acute myeloid leukaemia and higher risk myelodysplastic syndrome. We aimed to describe current practice and priorities for clinical trials in the prevention and management of febrile neutropenia across Australia\/New Zealand (ANZ), the United Kingdom (UK), Canada and Europe. We performed an international survey of haematologists recruited via professional networks. Eighty\u2010five unique hospitals were represented (ANZ\u2009=\u200920; Canada\u2009=\u200914; UK\u2009=\u200930; Europe\u2009=\u200921). Antibacterial prophylaxis was more commonly prescribed in Canada (79%) and the UK (83%) than in ANZ (30%) and Europe (48%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and was prescribed more frequently to outpatients than inpatients. The most common empiric treatment was piperacillin\u2013tazobactam monotherapy (66\/84, 79%), with nurse\u2010initiated antibiotic orders used in 35\/84 (42%). Screening for multidrug\u2010resistant organisms varied and was not usually used to direct antibiotic treatment. Antibiotic de\u2010escalation was attempted in most institutions; for uncomplicated short\u2010lived fever of unknown source, 39\/85 (46%) reported ceasing antibiotics at 72\u2009h and 68\/85 (80%) within 7\u2009days. For patients with bacteraemia, de\u2010escalation strategies included narrowing spectrum, oral switch and cessation after defined duration. Most respondents (79\/85, 93%) reported interest in recruiting for clinical trials. Clinical trials addressing practice variability in febrile neutropenia are needed, and are supported by haematologists.\n                  <\/jats:p>","DOI":"10.1111\/bjh.70358","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:13:04Z","timestamp":1770905584000},"page":"981-991","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An\u00a0international survey of current practice"],"prefix":"10.1111","volume":"208","author":[{"given":"Aleece","family":"MacPhail","sequence":"first","affiliation":[{"name":"Faculty of Medicine Nursing and Health Science Monash University  Clayton Victoria Australia"},{"name":"Monah Infectious Diseases Monash Health  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Loke","sequence":"additional","affiliation":[{"name":"Dana\u2010Farber Cancer Institute  Boston Massachusetts USA"},{"name":"University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-4083","authenticated-orcid":false,"given":"Brett L.","family":"Houston","sequence":"additional","affiliation":[{"name":"CancerCare Manitoba  Winnipeg Manitoba Canada"},{"name":"Max Rady College of Medicine University of Manitoba  Winnipeg Manitoba Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dendle","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Nursing and Health Science Monash University  Clayton Victoria Australia"},{"name":"Monah Infectious Diseases Monash Health  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-169X","authenticated-orcid":false,"given":"Andrea S.","family":"Henden","sequence":"additional","affiliation":[{"name":"Cancer Care Services, Royal Brisbane and Women's Hospital Metro North Hospital and Healthcare Service  Herston Queensland Australia"},{"name":"Faculty of Health Medicine and Behavioural Sciences  Herston Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-7988","authenticated-orcid":false,"given":"Robert","family":"Weinkove","sequence":"additional","affiliation":[{"name":"Cancer Immunotherapy Programme Malaghan Institute of Medical Research  Wellington New Zealand"},{"name":"Wellington Blood &amp; Cancer Centre Health New Zealand Capital Coast &amp; Hutt Valley  Wellington New Zealand"},{"name":"Department of Molecular Medicine &amp; Pathology University of Auckland  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Nursing and Health Science Monash University  Clayton Victoria Australia"},{"name":"Department of Infectious Diseases Alfred Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Geneva University Hospitals and Faculty of Medicine  Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Buetti","sequence":"additional","affiliation":[{"name":"Infection Control Program, Faculty of Medicine Geneva University Hospitals, WHO Collaborating Centre  Geneva Switzerland"},{"name":"INSERM, IAME Universit\u00e9 Paris\u2010Cit\u00e9  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-3075","authenticated-orcid":false,"given":"Catriona","family":"Parker","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Nursing and Health Science Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Peter MacCallum Cancer Centre  Parkville Victoria Australia"},{"name":"National Centre for Infections in Cancer Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology The University of Melbourne  Melbourne Victoria Australia"},{"name":"Victorian Infectious Diseases Service The Royal Melbourne Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Craddock","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital  Birmingham UK"},{"name":"University of Warwick  Warwick UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-4950","authenticated-orcid":false,"given":"Simon J.","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Trust  Oxford UK"},{"name":"John Radcliffe Hospital NHSBT  Oxford UK"},{"name":"University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-7185","authenticated-orcid":false,"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Nursing and Health Science Monash University  Clayton Victoria Australia"},{"name":"Department of Haematology Alfred Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Australasian Leukaemia and Lymphoma Group Supportive Care Working Group and UK AML\/Supportive Care Working Parties","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0624-z"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2893"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200732"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-623447"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2893"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255107"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181d8cc1d"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02338.x"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2024.103"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0811-y"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2012.0146"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02341.x"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091025"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.10.009"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.206"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04541-9"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.08.008"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154344"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac240"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02340.x"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx113"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.03.024"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00910-2022"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz777"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1043"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14157"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30211-9"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404991"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2969"},{"key":"e_1_2_12_35_1","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter\u2010Gvili A","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6211"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70358","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70358","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:42:34Z","timestamp":1782106954000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/bjh.70358"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70358","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2025-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}